Artificial intelligence’s potential in the financial services sector is at a tipping point, so NJIT associate professor Stephan Kudyba is exploring AI’s abilities in estimating risk among investors and markets…
Estimating Financial Risk Using AI in FinTech
Artificial Intelligence is gaining ground in a broad spectrum of industries, with its potential in the financial services sector particularly at a tipping point. As part of the growing subsector known as FinTech (Financial Technology), which involves using algorithms and other technology tools to process data toward improved financial activity, AI holds great promise in enhancing risk estimation among investors and the markets.
Murphy Unveils STEM fast-track Program for 3 NJ High Schools
Gov. Phil Murphy unveiled a new program for three of New Jersey’s urban high schools aimed at preparing the state’s students for careers in science and technology. Speaking at the Panther Academy in Paterson recently, Murphy unveiled the Pathway in Technology Early College High School (P-TECH) program where a student, upon completion, will graduate with both a high school diploma and associate degree.
Celgene Welcomes PhageNova as First Tenant in Biotech Research Incubator
Celgene Corporation has announced the selection of PhageNova Bio, Inc. as the first client in the Thomas O. Daniel Research Incubator and Collaboration Center, which offers state-of-the-art lab space, resources and support for promising scientists and companies to accelerate medical discoveries and innovations.
$2M Grant Awarded to Rutgers Cancer Institute Researcher
A five-year, $2,074,932 grant from the National Cancer Institute was awarded to Sharon Manne, Rutgers Cancer Institute of New Jersey’s associate director for cancer prevention, control and population research. The grant will support the expansion of behavioral intervention delivered through social media.
Princeton and Microsoft Collaborate to Tackle Challenges in Microbiology
In this project, Microsoft is helping Princeton better understand the mechanisms of biofilm formation by providing advanced technology that will greatly extend the type of research analysis capable today. Biofilms – surface-associated communities of bacteria – are the leading cause of microbial infection worldwide and kill as many people as cancer does.
New Jersey Innovation Institute Recruiting 10th Cohort for Health IT Connections Program The New Jersey Innovation Institute (NJII), an NJIT corporation, is calling for applications to participate in the 10th cycle of the Health IT Connections program, set to kick off on March 1, 2019.
New School at NJIT Aligns with Tech Workforce Needs
In 2016, the U.S. had 3 million more available STEM jobs than it had skilled workers to fill them. And The Wall Street Journal has reported there are 1.3 million STEM jobs available each year and only 600,000 new graduates in the STEM fields. That demand has been great for NJIT students, who are realizing an average of nearly three job offers before graduation and starting salaries almost 20 percent above those of their peers at other universities. But it also presents a challenge for the technology-driven industries that are the backbone of our economy.
Research with NJ Honored for Fostering Innovation within the Garden State
Research with NJ, a free portal that showcases New Jersey’s experts in science, technology, engineering and mathematics (STEM), was among the projects and industry leaders honored during the New Jersey Technology Council’s recent Awards Celebration.
Trends in Medical Devices and Leveraging 3D Printing
When: Wednesday, Dec. 5, 6 p.m. – 8 p.m.
Where: New Jersey Institute of Technology, 323 Dr. Martin Luther King Jr. Blvd., Newark
BioNJ’s Inspiring Women in STEM Conference
When: Friday, Dec. 7, 8:30 a.m. – 3:30 p.m.
Where: Sanofi, 55 Corporate Dr., Bridgewater
New Jersey: The Life Sciences Commercialization Hub
When: Monday, Dec. 10, 10:30 a.m. – 2 p.m.
Where: The Park Avenue Club, 184 Park Ave., Florham Park
CEO Forum – How to Create and Sustain High Performing Teams
When: Tuesday, Dec. 11, 8 a.m. – 10 a.m.
Where: 200 Jefferson Park, Whippany
BioNJ’s Patient Advocacy Summit
When: Thursday, Dec. 13, 1 p.m. – 6 p.m.
Where: Celgene Corporation, 179 Passaic Ave., Summit
